Midatech Pharma anno
Midatech Pharma announces positive pharmacokinetic data with Q-Octreotide
26. April 2016 02:00 ET | Midatech Pharma PLC
ABINGDON, England, April 26, 2016 (GLOBE NEWSWIRE) -- Midatech Pharma (AIM:MTPH; Nasdaq:MTP), the international specialty pharmaceutical company focused on commercialising and developing products in...
Midatech achieves po
Midatech achieves positive dosing data for OpsiSporin Uveitis programme
21. April 2016 02:00 ET | Midatech Pharma PLC
ABINGDON, England, April 21, 2016 (GLOBE NEWSWIRE) -- Midatech Pharma (AIM:MTPH) (Nasdaq:MTP), the international specialty pharmaceutical company focused on commercialising and developing products...
Midatech Pharma PLC 
Midatech Pharma PLC (“Midatech” or the “Company”) Audited financial results for the year ended 31 December 2015
13. April 2016 02:00 ET | Midatech Pharma PLC
Midatech will host a conference call and live Q&A session today (Wednesday 13 April 2016) at 1300 BST / 0800 EDT for analysts and investors to discuss the Annual Results. Dr Jim Phillips, Chief...
Midatech’s Commercia
Midatech’s Commercial Launch of Zuplenz® (Ondansetron) Oral Soluble Film to Prevent Post-Operative, Chemotherapy and Radiation-Induced Nausea and Vomiting in US
11. April 2016 02:00 ET | Midatech Pharma PLC
ABINGDON, England, April 11, 2016 (GLOBE NEWSWIRE) -- Midatech Pharma (AIM:MTPH); (Nasdaq:MTP), the international specialty pharmaceutical company focused on commercialising and developing...
Midatech Pharma PLC
Midatech Pharma PLC (“Midatech”, the “Company” or the “Group”) Pre-Close Trading Update
06. Januar 2016 02:00 ET | Midatech Pharma PLC
OXFORD, United Kingdom, Jan. 06, 2016 (GLOBE NEWSWIRE) -- Midatech Pharma (AIM:MTPH, Nasdaq: MTP), the international specialty pharmaceutical company focused on developing and commercialising...
Midatech Completes A
Midatech Completes Acquisition of Zuplenz®
30. Dezember 2015 02:00 ET | Midatech Pharma PLC
OXFORDSHIRE, United Kingdom, Dec. 30, 2015 (GLOBE NEWSWIRE) -- Midatech Pharma (“Midatech” or the “Company” or the “Group”) (AIM:MTPH) (Nasdaq:MTP), the international specialty pharmaceutical...
Midatech Agrees to A
Midatech Agrees to Acquire Marketed Oncology Product, Zuplenz®, From Galena Biopharma, Inc.
18. Dezember 2015 02:00 ET | Midatech Pharma PLC
OXFORDSHIRE, United Kingdom, Dec. 18, 2015 (GLOBE NEWSWIRE) -- Midatech Pharma (AIM:MTPH), the international specialty pharmaceutical company focused on developing and commercialising products in...